Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report. Dermatol Pract Concept [Internet]. 2024 Oct. 30 [cited 2024 Dec. 10];14(4):e2024252. Available from: https://dpcj.org/index.php/dpc/article/view/4512